The aim of this study was to investigate the infections due to OXA-48 carbapenemase-producing bacteria in tertiary hospitals in Kuwait (September 2011 to April 2013) and to determine the sequence types (STs) of the corresponding isolates. Eleven OXA-48 carbapenemase-producing Enterobacteriaceae isolates were recovered from patients treated in nine different hospitals in Kuwait. Susceptibility testing to eighteen antibiotics was done using the E-test. PCR assays were performed for the detection of genes encoding extended-spectrum β-lactamases (ESBLs) (blaCTX-M, blaSHV, and blaTEM) and carbapenemases (blaOXA-48, blaVIM, blaNDM, blaIMP, blaGIM, and blaKPC). STs were determined by Multilocus Sequence Typing. Seven Klebsiella pneumoniae, two Escherichia coli, one Enterobacter cloacae, and one Morganella morganii harbored the blaOXA-48 gene. The K. pneumoniae and E. coli belonged to seven and two different STs, respectively, which were not related to those reported from this region. The majority of the isolates carried either blaCTX-M or blaSHV genes and showed a multidrug-resistant phenotype, including resistance to tigecycline. Multidrug-resistant Enterobacteriaceae harboring the blaOXA-48 gene are emerging in Kuwait with different STs compared to those identified in other countries of the region. Detection of OXA-48-producing Enterobacteriaceae in Kuwait is important to prevent its rapid spread.
Get full access to this article
View all access options for this article.
References
1.
AdlerA., ShklyarM., SchwaberM.J., Navan-VeneziaS., DhaherY., EdgarR., SolterE., BenensonS., MasarwaS., and GarmeliY.2011. Introduction of OXA-48-producing Enterobacteriaceae to Israeli hospitals by medical tourism. J. Antimicrob. Chemother., 66:2763–2766.
2.
BushK., and JacobyG.A.2010. Updated functional classification of β-lactamases. Antimicrob. Agents Chemother., 54:969–976.
3.
[CLSI] Clinical and Laboratory Standards Institute. Performance standards for Antimicrobial susceptibility testing, twenty second informational supplement. 34, M100-S22. Clinical and Laboratory Standard Institute, Wayne, PA, 2012.
4.
DashN., PanigrahiD., Al ZarouniM., DarwishD., GhazawiA., SonnevendA., PalT., YasinF., and Al HadiS.2014. High incidence of New Delhi metallo-beta-lactamase–producing Klebsiella pneumoniae isolates in Sharja, United Arab Emirates. Microb. Drug Resist., 20:52–56.
5.
DayK.M., PikeR., WinstanleyT.G., LanyonC., CummingsS.P., RazaM.W., WoodfordN., and PerryJ.D.2013. Use of faropenem as an indicator of carbapenemase activity in the Enterobacteriaceae. J. Clin. Microbiol., 51:1881–1886.
6.
DiancourtL., PassetV., VerhoefJ., GrimontP.A.D., and BrisseS.2005. Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates. J. Clin. Microbiol., 43:4178–4182.
7.
DortetL., PoirelL., Al YaqoubiF., and NordmannP.2012. NDM-1, OXA-48 and OXA-181 carbapenemase–producung Enterobacteriaceae in Sultanate of Oman. Clin. Microbiol. Infect., 18:E144–E148.
8.
DoumithM., EllingtonM.J., LivermoreD.M., and WoodfordN.2009. Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK. J. Antimicrob. Chemother., 63:659–667.
9.
HashimotoA., NagamatsuM., OhmagariN., HayakawaK., KatoY., and KirikaeT.2014. Isolation of OX-48 carbapenemase-producing Klebsiella pneumoniae ST101 from an overseas traveler returning to Japan. Jpn. J. Infect. Dis., 67:120–121.
10.
HuangT.-D., PoirelL., BogaertsP., BerhinC., NordmannP., and GlupczynskiY.2014. Temocillin and piperacillin/tazobactam resistance by disc diffusion as antimicrobial surrogate markers for the detection of carbapenemase-producing Enterobacteriaceae in geographical areas with a high prevalence of OXA-48 producers. J. Antimicrob. Chemother., 69:445–450.
11.
LartigueM.-F., PoirelL., PoyartC., Reglier-PoupetH., and NordmannP.2007. Ertapenem resistance of Escherichia coli. Emerg. Infect. Dis., 13:315–317.
12.
MatasejeL.F., BoydD.A., HoagL., ImperialM., LefebvreB., MillerM., PoutanenS.M., RoscoeD., WilleyD., and MulveyM.R.2013. Carbapenem-hydrolyzing oxacillinase-48 and oxacillinase-181 in Canada. Emerg. Infect. Dis., 19:157–159.
13.
MathersA.J., HazenK.C., CarrollJ., YehA.J., CoxH.L., BonomoR.A., and SifriC.D.2013. First clinical cases of OXA-48-producing carbapenem–resistant Klebsiella pneumoniae in the United States: the ‘menace’ arrives in the New World. J. Clin. Microbiol., 51:680–683.
14.
MimozO., GregoireN., PoirelL., MarliatM., CouetW., and NordmannP.2012. Broad- spectrum β-lactam antibiotics for treating experimental peritonitis in mice due to Klebsiella pneumoniae producing the carbapenemase OXA-48. Antimicrob. Agents Chemother., 56:2759–2760.
15.
NordmannP., DoretL., and PoirelL.2012. Carbapenem resistance in Enterobacteriaceae: here is the storm!. Trends Mole. Med., 18:263–272.
16.
NordmannP., GirlichD., and PoirelL.2012. Detection of carbapenemase producers in Enterobacteriaceae by use of a novel screening medium. J. Clin. Microbiol., 50:2761–2766.
17.
NordmannP., NaasT., and PiorelL.2011. Global spread of carbapenemase-producing Enterobacteriaceae. Emerg. Infect. Dis., 17:1791–1798.
18.
NordmannP., PoirelL., and DortetL.2012. Rapid detection of carbapenemase-producing Enterobacteriaceae. Emerg. Infect. Dis., 18:1503–1507.
19.
PoirelL., CarbonnelleE., BernabeuS., GutmannL., RotimiV., and NordmannP.2012. Importation of OXA-48-producing Klebsiella pneumoniae from Kuwait. J. Antimicrob. Chemother., 67:2051–2052.
20.
PoirelL., HéritierC., and NordmannP.2004. Chromosome-encoded ambler class D ß-lactamase of Shewanella oneidensis as a progenitor of carbapenem-hydrolyzing oxacillinase. Antimicrob. Agents Chemother., 48:348–351.
21.
PoirelL., Héritier CC., TolünV., and NordmannP.. 2004. Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob. Agents Chemother., 48:15–22.
22.
PoirelL., PodglajenI., LawrenceC., and NordmannP.2011. Emergence of OXA-48-producing Escherichia coli clone ST38 in France. Antimicrob. Agents Chemother., 55:4937–4938.
23.
PoirelL., PotronA., and NordmannP.2012. OXA-48-like carbapenemases: the phantom menace. J. Antimicrob. Chemother., 67:1597–1606.
24.
PoirelL., WalshT.R., CuvillierV., and NordmannP.2011. Multiplex PCR for the detection of acquired carbapenemase genes. Diag. Microbiol. Infect. Dis., 70:119–123.
25.
PotronA., PoirelL., RondinaudE., and NordmannP.2013. International spread of OXA-48 beta- lactamase-producing Enterobacteriaceae over a 11–year period, 2001 to 2011. Eurosurveillance, 18: pii=20549.
26.
RotimiV.O., JamalW., PalT., SovennedA., and AlbertM.J.2008. Emergence of CTX-M-15 type extended spectrum β-lactamase–producing Salmonella spp. in Kuwait and United Arab Emirates. J. Med. Microbiol., 57:881–886.
27.
ShinS.Y., BaeI.K., KimJ., JeongS.H., YongD., KimJ.M., and LeeK.2012. Resistance to carbapenems in sequence type 11 Klebsiella pneumoniae is related to DHA-1 and loss of OmpK35 and/or OmpK36. J. Med. Microbiol., 61:239–245.
28.
StolleI., Prenger-BerninghoffE., StammI., ScheufenS., HassdenteufelE., GuentherS., BetheA., PfeiferY., and EwersC.2013. Emergence of OXA-48 carbapenemase-producing Escherichia and Klebsiella pneumoniae in dogs. J. Antimicrob. Chemother., 68:2802–2808.
29.
SzczepanowskiR., LinkeB., KrahnI., GaremannK.-H., GutzkowT., EichlerM., PuhlerA., and SchluterA.2009. Detection of 140 clinically relevant antibiotic-resistance genes in the plasmid metagenome of wastewater treatment plant bacteria showing reduced susceptibility to selected antibiotics. Microbiology, 155:2306–2319.
30.
TenoverF.C., ArbeitR.D., GoeringR.V., MickelsenP.A., MurrayB.E., PersingD. H., and SwaminathanB.1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol., 33:2233–2239.
31.
VoulgariE., ZarkotouO., RanellouK., KarageorgopoulosD.E., VrioniG., MamaliV., Themeli-DigalakiK., and TsakrisA.2013. Outbreak of OXA-48 carbapenemase-producing Klebsiella pneumoniae in Greece involving an ST11 clone. J. Antimicrob. Chemother., 68:84–88.
32.
WiskirchenD.E., NordmannP., CrandonJ.L., and NicolauD.P.2014. Efficacy of humanized carbapenem and ceftazidime regimens against Enterobacteriaceae producing OXA-48 carbapenemase in a murine infection model. Antimicrob. Agents Chemother., 58:1678–1683.
33.
ZowawiH.M., SartorA.L., BalkhyH.H., WalshT.R., Al JohaniS.M., AlJindanR.Y., AlfaresiM., IbrahimE., AlJardaniA., Al-AbriS., AlSalmanJ., DashtiA.A., KutbiA.H., SchlebuschS., SidjabatH.E., and PetersonD.L.2014. Molecular characterization of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in the countries of the Gulf Cooperation Council: dominance of OXA-48 and NDM producers. Antimicrob. Agents Chemother., 58:3085–3090.
